How do you use Kevzara (sarilumab) for the treatment of rheumatoid arthritis?
Medically reviewed by Drugs.com Last updated on Sep 23, 2019.
Official Answerby Drugs.com
Kevzara (sarilumab) used to treat moderate-to-severe rheumatoid arthritis in patients who failed, or cannot tolerate at least one other disease modifying antirheumatic drug (DMARD). Kevzara may be used alone as monotherapy, or in combination with methotrexate or other conventional DMARDs.
The recommended dosage of Kevzara is 200 mg once every two weeks given as a subcutaneous injection, which can be self-administered. The dosage can be reduced from 200 mg to 150 mg once every two weeks, as needed, to help manage certain laboratory abnormalities (neutropenia, thrombocytopenia, and liver enzyme elevations).
Kevzara is available as a single-use pre-filled syringe or single-use pre-filled pen. The injection can be self-injected into the front of the thigh or abdomen, but not the area 2 inches around the navel. If somebody else administers the injection, it can also be given in the upper arm.
Related Medical Questions
- What are the new drugs for the treatment of rheumatoid arthritis (RA)?
- How long does it take for Kevzara to work?
- Does Kevzara cause weight gain?
- What causes osteoporosis?
- Aleve vs Ibuprofen: What's the difference?
- Tylenol vs Advil: What's the difference?
- What is the difference between Amjevita and Humira?